| Date Filed | Type | Description |
| 05/25/2023 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Envista Holdings Corp|
Txns:
| Granted 5,425 shares
@ $0 |
|
| 05/15/2023 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 2,803 shares
@ $0
Granted 898 shares
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Unknown transaction of 3,239 shares
@ $28.25, valued at
$91.5k
Unknown transaction of 5,011 shares
@ $28.25, valued at
$141.6k
Unknown transaction of 29,262 shares
@ $28.25, valued at
$826.7k
Unknown transaction of 120,064 options to buy
@ $25.1, valued at
$3M
Unknown transaction of 3,390 options to buy
@ $21, valued at
$71.2k
Unknown transaction of 82,387 options to buy
@ $17.01, valued at
$1.4M
Unknown transaction of 5,734 options to buy
@ $16.5, valued at
$94.6k
Unknown transaction of 12,500 options to buy
@ $13.79, valued at
$172.4k
Unknown transaction of 9,666 options to buy
@ $11.84, valued at
$114.4k
Unknown transaction of 3,473 options to buy
@ $42.05, valued at
$146k
Unknown transaction of 6,035 options to buy
@ $26.05, valued at
$157.2k
|
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 3,239 shares
@ $0
Granted 5,734 options to buy
@ $16.5, valued at
$94.6k
|
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 3,390 options to buy
@ $21, valued at
$71.2k
|
|
| 06/16/2020 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,446 shares
@ $0
Granted 5,000 options to buy
@ $61.31, valued at
$306.6k
|
|
| 06/08/2020 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 5,011 shares
@ $0
Granted 9,666 options to buy
@ $11.84, valued at
$114.4k
|
|
| 05/29/2020 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Envista Holdings Corp|
Txns:
| Granted 8,230 restricted stock units
@ $0 |
|
| 05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Envista Holdings Corp|
Txns:
| Granted 2,035 shares
@ $0 |
|
| 12/20/2019 |
3
| GALLAHUE KIERAN (Director) has filed a Form 3 on Envista Holdings Corp |
| 10/02/2019 |
4
| GALLAHUE KIERAN (Executive Chairman) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 17,202 shares
@ $0
Granted 82,387 options to buy
@ $17.01, valued at
$1.4M
|
|
| 06/17/2019 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,654 shares
@ $0
Granted 5,000 options to buy
@ $56.5, valued at
$282.5k
|
|
| 05/13/2019 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 1,323 shares
@ $0
Granted 414 shares
@ $0 |
|
| 05/08/2019 |
4
| GALLAHUE KIERAN (Executive Chairman) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 180,096 options to buy
@ $25.1, valued at
$4.5M
|
|
| 07/10/2018 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 1,674 shares
@ $0
Granted 3,070 shares
@ $0
Granted 2,500 options to buy
@ $44.79, valued at
$112k
Granted 4,583 options to buy
@ $44.79, valued at
$205.3k
|
|
| 07/10/2018 |
3
| GALLAHUE KIERAN (Director) has filed a Form 3 on ARENA PHARMACEUTICALS INC |
| 06/07/2018 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 1,514 shares
@ $0
Granted 3,473 options to buy
@ $42.05, valued at
$146k
|
|
| 05/22/2018 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Gifted 2,034 shares
@ $0
Granted 1,655 shares
@ $0
Granted 479 shares
@ $0
Gifted 2,034 shares
@ $0 |
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/17/2016 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 1,941 shares
@ $0
Granted 583 shares
@ $0 |
|
| 05/17/2016 |
4
| GALLAHUE KIERAN (Director) has filed a Form 4 on Intersect ENT, Inc. |
| 12/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|